Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncogene. 2011 Jul 28;30(30):3328-35. doi: 10.1038/onc.2011.57. Epub 2011 Mar 14.

Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.

Author information

1
Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA. bgrandinetti@gnf.org

Abstract

Lung cancer is the most common cause of cancer-related mortality worldwide. Here, we report elevated expression of tribbles homolog 2 (TRIB2) in primary human lung tumors and in non-small cell lung cancer cells that express low levels of differentiation-inducing transcription factor CCAAT/enhancer-binding protein alpha (C/EBPα). In approximately 10-20% of cases, elevated TRIB2 expression resulted from gene amplification. TRIB2 knockdown was found to inhibit cell proliferation and in vivo tumor growth. In addition, TRIB2 knockdown led to morphological changes similar to C/EBPα overexpression and correlated with increased expression and activity of C/EBPα. TRIB2-mediated regulation of C/EBPα was found to occur through the association of TRIB2 with the E3 ligase TRIM21. Together, these data identify TRIB2 as a potential driver of lung tumorigenesis through a mechanism that involves downregulation of C/EBPα.

PMID:
21399661
PMCID:
PMC3382061
DOI:
10.1038/onc.2011.57
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center